日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Beyond body mass index: visceral adiposity and metabolic alterations as early markers of atrial dysfunction and atrial fibrillation in midlife

超越体重指数:内脏脂肪和代谢改变是中年心房功能障碍和心房颤动的早期标志

Borizanova, Angelina; Kinova, Elena; Spasova, Natalia; Goudev, Assen

Impact of CPAP Therapy Adherence on Time to First Recurrence of Paroxysmal Atrial Fibrillation in Patients with Severe Obstructive Sleep Apnea

CPAP治疗依从性对重度阻塞性睡眠呼吸暂停患者阵发性房颤首次复发时间的影响

Kalaydzhiev, Petar; Ilieva, Radostina; Spasova, Natalia; Yakov, Slavi; Markov, Dimitar; Georgieva, Neli; Kinova, Elena; Goudev, Assen

Extrinsic Left Atrial Compression: An Echocardiography-Guided Diagnosis Illustrated by Two Clinical Cases and a Structured Review of Published Cases

左心房外源性压迫:超声心动图引导下的诊断——以两例临床病例和已发表病例的系统性回顾为例

Borizanova, Angelina; Kinova, Elena; Beyti, Semra; Angelov, Todor; Getsov, Plamen; Goudev, Assen

The giant left atrium: when the heart outgrows the chest

巨大的左心房:心脏超出胸腔容纳范围。

Borizanova, Angelina; Kinova, Elena; Beyti, Semra; Goudev, Assen

Effects of SGLT2 Inhibitors on Sleep Apnea Parameters and Cheyne-Stokes Respiration in Patients with Acute Decompensated Heart Failure: A Prospective Cohort Study

SGLT2抑制剂对急性失代偿性心力衰竭患者睡眠呼吸暂停参数和陈-施氏呼吸的影响:一项前瞻性队列研究

Kalaydzhiev, Petar; Velikova, Tsvetelina; Davidkova, Yanitsa; Voynova, Gergana; Borizanova, Angelina; Spasova, Natalia; Georgieva, Neli; Ilieva, Radostina; Kinova, Elena; Goudev, Assen

Integrated Advanced Echocardiographic and Biomarker Approach for the Early Detection of Atrial Cardiomyopathy in Middle-Aged Patients With Atrial Fibrillation

综合运用先进超声心动图和生物标志物方法早期检测中年房颤患者房性心肌病

Borizanova, Angelina; Kinova, Elena; Koleva, Veselina; Tica, Otilia; Kalaydzhiev, Petar R; Goudev, Assen

Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial

根据既往口服抗凝剂使用情况,对房颤患者使用阿司匹林或阿哌沙班进行分析:OCEANIC-AF 随机临床试验的亚组分析

Alexander, John H; Lydon, Elizabeth J; Piccini, Jonathan P; Viethen, Thomas; Oldgren, Jonas; Goodman, Shaun G; Steffel, Jan; Russo, Andrea M; van Gelder, Isabelle C; Ferdinand, Keith C; Lopes, Renato D; Mundl, Hardi; Benczur, Bela; Gómez-Doblas, Juan José; Glikson, Michael; Goudev, Assen; Grove, Erik L; Halvorsen, Sigrun; Kiviniemi, Tuomas; Martin, Anne-Céline; Sandhu, Roopinder K; Vinereanu, Dragos; Rockhold, Frank W; Caso, Valeria; Coppolecchia, Rosa; Patel, Manesh R

Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases

三甲胺N-氧化物与具有心血管疾病危险因素的中年患者的心血管风险和血管改变之间的关联

Spasova, Natalia; Somleva, Desislava; Krastev, Bozhidar; Ilieva, Radostina; Borizanova, Angelina; Svinarov, Dobrin; Kinova, Elena; Goudev, Assen

CPAP Treatment at Home after Acute Decompensated Heart Failure in Patients with Obstructive Sleep Apnea

阻塞性睡眠呼吸暂停患者急性失代偿性心力衰竭后居家CPAP治疗

Kalaydzhiev, Petar; Borizanova, Angelina; Georgieva, Neli; Voynova, Gergana; Yakov, Slavi; Kocev, Tsvetan; Tomova-Lyutakova, Galya; Krastev, Bozhidar; Spasova, Natalia; Ilieva, Radostina; Kinova, Elena; Goudev, Assen

Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction

ENDEAVOR 研究的原理和设计:一项序贯的 2b-3 期随机临床试验,旨在评估髓过氧化物酶抑制剂对射血分数保留或轻度降低的心力衰竭患者的症状和运动能力的影响

Lund, Lars H; Lam, Carolyn S P; Pizzato, Patricia E; Gabrielsen, Anders; Michaëlsson, Erik; Nelander, Karin; Ericsson, Hans; Holden, Julie; Folkvaljon, Folke; Mattsson, Andrea; Collén, Anna; Aurell, Malin; Whatling, Carl; Baldus, Stephan; Drelich, Grzegorz; Goudev, Assen; Merkely, Béla; Bergh, Niklas; Shah, Sanjiv J